Mednet Logo
HomePediatric Hematology/Oncology
Pediatric Hematology/Oncology

Pediatric Hematology/Oncology

Clinical discussions on pediatric blood disorders, childhood cancers, and specialized treatment protocols.

Recent Discussions

How long should patients treated with frontline therapy for Hodgkin lymphoma wait before attempting to conceive a child?

1
1 Answers

Mednet Member
Mednet Member
Pediatric Hematology/Oncology · Children’s Wisconsin

For males: All patients should have a fertility consultation to discuss fertility preservation prior to initiation of chemotherapy ABVD and BEACOPP regimens significantly reduce male fertility to varying effects depending on treatment duration. ABVD temporarily causes significant reductions in male ...

For patients with suspected complement-mediated TMA, are there specific clinical or laboratory parameters that can help guide the decision for starting empirical treatment (e.g., eculizumab) while awaiting the results of complement testing?

5
1 Answers

Mednet Member
Mednet Member
Nephrology · Albert Einstein College of Medicine of Yeshiva University

I just want to point out that hemolytic microangiopathy (as seen on the peripheral smear by our Hematology colleague) is paramountly important in determining the presence of TMA. Laboratory parameters may be misleading. I have seen even ADAMT13 levels very low in sepsis and DIC process. Therefore lo...

What are magic mouthwash alternatives that you would recommend?

24
9 Answers

Mednet Member
Mednet Member
Radiation Oncology · The Toledo Clinic

Many of our patients will make their own DIY MMW per Phil's My Pharmacist (YouTube) instructions -- uses benzocaine/Cepacol lozenges -- they say it's much more effective than the compounded one from the pharmacy. It is also more economical.If the majority of bothersome mucositis is in the oral cavit...

How would you manage a patient with antiphospholipid syndrome in the setting of severe steroid-refractory thrombocytopenia?

2 Answers

Mednet Member
Mednet Member
Rheumatology · NYU Langone Health

Dr. @Dr. First Last answered the question of severe thrombocytopenia in a patient with APS and an acute thrombotic stroke. I agree with his approach. However, this “between a rock and a hard place” clinical scenario does also appear not infrequently during the chronic management of patients with APS...

For AML patients, when do you stop antiinfective agents?

1 Answers

Mednet Member
Mednet Member
Hematology · University of Chicago

Our practice is typically to continue an anti-viral throughout induction/consolidation without stopping the agent. We typically utilize anti-bacterial and anti-fungal when the absolute neutrophil count (ANC) is under 500 and then stop them once the ANC recovers to above 500. Our preferred anti-funga...

How would you manage a patient with radiation pneumonitis who remains symptomatic on steroids?

1
2 Answers

Mednet Member
Mednet Member
Radiation Oncology · Tennessee Oncology

Engage your Pulmonology colleagues to assist in these difficult cases. Important to rule out other causes of persistent symptoms including infectious processes. Rebronch can be helpful for infectious work up and/or determining the nature of the inflammatory process that is ongoing (for example, the ...

When (if ever) do you check for anti-platelet antibodies for workup of thrombocytopenia?

1 Answers

Mednet Member
Mednet Member
Hematology · University of Washington

Routinely available anti-platelet antibody tests have a sensitivity too high and specificity too low to be of much clinical use. A patient's response to first line therapy (steroids or IVIg) is most telling and if there is no response, a bone marrow is warranted as it would be atypical for ITP. Ther...

How would you adjust the steroid dose for steroid-induced psychosis in a patient being treated for secondary HLH with the HLH-94 protocol?

1 Answers

Mednet Member
Mednet Member
Pediatric Hematology/Oncology · UCSF Medical Center-Mission Bay

If disease status allows weaning, we slowly wean per recommendations in HLH94. If they need steroids because of significant hyperinflammation that is damaging, then we add risperidone, which generally works very well.

Would you anticoagulate a patient with splenic infarctions in the setting of CMV viremia?

1 Answers

Mednet Member
Mednet Member
Hematology · Medical University of South Carolina

Based on my general knowledge/experience, I would consider CMV viremia as temporary, short-lived risk factor for a thrombotic event on a part of other inflammatory conditions, and outside of other indications for anticoagulation (e.g., atrial fibrillation, etc), my inclination would be to conclude ...

Does the presence of asparaginase antibodies on Granger Genetics testing indicate need to switch asparaginase formulations?

1 Answers

Mednet Member
Mednet Member
Pediatric Hematology/Oncology · Seattle Children's Hospital, University of Washington

I would rely on the serum asparaginase activity (SAA) assay rather than the antibody testing. SAA has proven to be a reliable predictor of asparagine depletion and is a widely acceptable method for therapeutic drug monitoring. On the other hand, asparaginase antibody testing has not been consistentl...